FW: Prof Ginger Graham

[Kloeblen, Emily]

When: Thursday, November 03, 2011 3:30 PM-4:30 PM (UTC-05:00) Eastern Time (US & Canada).

Where: Aldrich 209

 

Note: The GMT offset above does not reflect daylight saving time adjustments.

 

*~*~*~*~*~*~*~*~*~*

 

Reminder about the meeting with Ginger Graham today at 3:30 in Aldrich 209.  Hope to see you there if you can make it.

Marty

 

-----Original Appointment-----
From: eklo...@mba2012.hbs.edu [mailto:eklo...@mba2012.hbs.edu]
Sent: Sunday, October 30, 2011 11:42 PM
To: Lucena, Ann; Sunder, Anushka; Craven, Matthew; Ghorawat, Amit; Dijols, Frederic; eklo...@mba2012.hbs.edu; Cheng, Royce; Venkiteswaran, Anita; Stein, Andrew; Roslund, Jeffrey; Wanamaker, Benjamin; Martin Grasse; Dickson, Alexandra; Ottensmann, Sandra; Plimpton, Lisa; Bedi, Aparna; Saltzman, Alexander; Wallace, Courtney; Lin, ZiHan; Badani, Romish; glas...@mba2013.hbs.edy; Matarese, Melissa; Masterson, Thomas; Grasse, Martin; Kibata, Koichi; Elbogen, Michael; Leimberg, Ross; Munns, Alexander; Patil, Anura; Leong, Shirley; Tu, Shunde; Kester, Kirsten; Pflepsen, Lauren; Haldipur, Nina; Niculcea, Ioana; Chiou, Albert; Bellardine Black, Carissa; jstr...@gmail.com; Sakai, Yukiko; Brooks, Katherine; Chang, Michael; Ullrich, Gunnar; Richardson, John; Francis, Said; Zapata, Josue; Kennedy, Melissa; Jiang, Shanshan; Tyson, Emily; Ceballos Carrascosa, Patricia; Milne, Avaleigh; Ni, Svetlana; Ryan, Meaghan; Singh, Raj; Kazzaz, Shwan; Pishny, Eleanor; Lesser, Jenny; Wong, Jadelind; Galezewski, Ellen; Garg, Tulika; Geronemus, Greg; Lai, Jonathan; Liebermann, Ethan; Aciman, Igal
Subject: FW: Prof Ginger Graham
When: Thursday, November 03, 2011 3:30 PM-4:30 PM (UTC-05:00) Eastern Time (US & Canada).
Where: Aldrich 209

 

 

When: Thursday, November 03, 2011 3:30 PM-4:30 PM (UTC-05:00) Eastern Time (US & Canada).

Where: Aldrich 209

 

Note: The GMT offset above does not reflect daylight saving time adjustments.

 

*~*~*~*~*~*~*~*~*~*

 

Device and Diagnostic Special Interest Group,

 

Please see below for a chance to meet with Ginger Graham, former Group Chairman of Guidant Corporation and later President and CEO of Amylin Pharmaceuticals.  She will candidly chat with us about her experience in the medical technology and biotech industries and answer questions from students.

 

This event is targeted at ECs as it is during RC CID week, but RCs feel free to come if you are available.

 

Marty

 

-----Original Appointment-----

From: Kloeblen, Emily

Sent: Sunday, October 30, 2011 11:42 PM

To: Kloeblen, Emily; Saltzman, Alexander; Richardson, John; Lesser, Jenny; Haldipur, Nina; Patil, Anura; Ghorawat, Amit; Garg, Tulika; Bedi, Aparna; Leimberg, Ross; Chang, Michael; Lin, ZiHan; Matarese, Melissa; Kennedy, Melissa; Venkiteswaran, Anita; Liebermann, Ethan; Wong, Jadelind; Ryan, Meaghan; Pflepsen, Lauren; Aciman, Igal; Singh, Raj; Kibata, Koichi; Grasse, Martin; Ni, Svetlana; Milne, Avaleigh; Munns, Alexander; Galezewski, Ellen; Pishny, Eleanor; Geronemus, Greg; Niculcea, Ioana; Zapata, Josue; Elbogen, Michael; Badani, Romish; Sakai, Yukiko; Bellardine Black, Carissa; Lucena, Ann; Tyson, Emily

Subject: Prof Ginger Graham

When: Thursday, November 03, 2011 3:30 PM-4:30 PM (UTC-05:00) Eastern Time (US & Canada).

Where: Aldrich 209

 

 

When: Thursday, November 03, 2011 3:30 PM-4:30 PM (UTC-05:00) Eastern Time (US & Canada).

Where: Aldrich 209

 

Note: The GMT offset above does not reflect daylight saving time adjustments.

 

*~*~*~*~*~*~*~*~*~*

 

HBS Professor and entrepreneur extraordinaire Ginger Graham will talk about her leadership experience in both biotech and medical devices sectors as well as her perspective on the state of the healthcare industry.

 

BACKGROUND

Ginger Graham teaches a course in entrepreneurship at the Harvard Business School and consults to first-time CEO’s in the areas of leadership, strategy, board-effectiveness, and organization-building.

She is the former President and Chief Executive Officer of Amylin Pharmaceuticals, a biopharmaceutical company based in San Diego, CA, focused on diabetes and obesity.  During Ginger’s tenure at Amylin, the company launched two first-in-class medicines for people with diabetes, was listed on the Nasdaq 100 and was rated as one of the Top 10 places in the industry for scientists to work. 

Prior to her time at Amylin, Ginger was Group Chairman, Office of the President for Guidant Corporation, a major cardiovascular medical device manufacturer based in Indianapolis, IN.  During Ginger’s tenure at Guidant, the company launched the world’s leading stent platform, was listed in the Fortune 500, was recognized by Fortune Magazine as one of the Best Companies to Work For in America, and was included in Industry Week Magazine’s 100 Best Managed Companies in the World. 

Ginger has received numerous awards and honors including being named as the Emerging Company Executive of the Year by the Global Health Council in 2005, a Finalist in Marketwatch’s CEO of the Year in 2006, and named as the American Diabetes Association’s Woman of Valor award in 2006.  She was included in Pharma VOICE’s “100 of the Most Inspiring People” list in 2006 and World Pharmaceuticals magazine named her number 10 on a list of 40 most influential people in the industry in 2007.  Ginger was the first woman CEO named to the PhRMA Board and Executive Committee.

Ms. Graham serves on the Boards of Directors for Walgreen Co., Genomic Health, Inc., Proteus Biomedical, ICAT Managers, Paraline Holdings, Ltd., and the American Diabetes Association Research Foundation where she serves as Vice Chair.  Ms. Graham is a member of the Harvard Business School Health Industry Alumni Advisory Board, The University of Arkansas Chancellor’s Board of Advisors and the University of Colorado Biosciences Advisory Board.  She also serves on the Advisory Boards for the Kellogg Center for Executive Women and the Women Business Leaders of the US Health Care Industry Foundation.  She serves on the Editorial Advisory Board for the Journal of Life Sciences publication, frequently speaks at Business Schools and has written for Harvard Business Review.

Ginger received a Bachelor of Science in agricultural economics from the University of Arkansas, and holds an MBA, with distinction, from Harvard University.